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Kinetic Aspects of the Interaction of Blood-Clotting
Enzymes
II. The Relation between Clotting Time anil Plasma Concentration
in Prothrombin-Time Estimations
H. C. Hnuxnn, T. Srnpnl*, R.Ar,mnLnx* and E. A. Lonr,renn
F.  K .  SCEATTAUER,-VER,LAG .  STUTTGART
As a rule, clotting times obtained in prothrombin-time estimations become longer
the more a plasma is diluted. This holds for the original Quick method as well as for
any of its modifications. The estimation of the way in which clotting time (t6) varies
with the concentration (C) of the clotting factors in the plasma being tested, may
be of considerable importance. Such estimation is done by analysis of the curve that
gives t. as a function of C, which will reveal the nature of the function t. : f(Q;.
It has been claimed (I,2) t}lrat this function is hyperbolic, i. e. that the plot of t
against 1/C is a straight line. This assumption yields useful results in the study of
various kinds of thromboplastins (3, 4).
The purpose of this study was to assess the nature of tc : f(C) for the case of
dilutions of normal plasma tested with the Thrombotest reagent; to see what influences
affect the parameters of this function and to investigate briefly the results with other
thromboplastins.
Materials antl Methorls
Normal Plasm,a (N. Pl.): pooled platelet-free citrated plasma from at least 30 healthy normals
(mean age around 30 years), freed of platelots by centrifugation for 30' aI L2,5O0 g and storod
a.t -25" C in 1 mI aliquots. Three differont batches of pooled normal plasma were used..
Factor Vll-def,c,ient pl,asmo: plasma from a patient with congenital factor Yll-deficiency,
propared in the same way as the normal plasma. This plasma contained 80o/o factor X.
Eactor X-def,c,ient plasma: plasma from a patient suffering from amyloidosis with consequent,
factor X-deficiency (5), kindly suppliod by Dr. G. den Ottolander (Dijkzigt Hospital, Rotterdam).
llhrom,bopl,astin,.'human brain thromboplastin according to Owren and Aas (6).
Roche Thrombogtlastin: batch no. 8604066; S. A. Hoffmann-La Roche & Co. A. G., Basle,
Switzerland,
Si,mplasti,n: batch no. 0024016; Warner-Chilcott Laboratories, N. J., U. S. A.
Thron'rbotest: according to Owren: batch nos. 672 a,nd 710; Nyegaard & Co. A/S, OsIo, Norway.
Ifnless otherwise stated, the dry matorial from one large ampoule was dissolved in l1ml of
3.2 mM CaCIr. This material was a gift from Pharmachemie N. V., I{aarlem, The Netherlands.
Thebwfferrsedfor dilution was Michaelis buffer (pH 7.4).
The moment of clotting waq assessed with a I(oIIe hook, and the time (t.) between tho beginning
of the reaction and the momenf, of clottine was measurod with a chronometer. The reactions were
carriod out at 37 + 0.1" C.
*) Present address: State llniv. of New York at Buffalo, Med. Sch., N. Y., U. S. A.
* *) Presont address : R ivadavia Hospital, Buenos Aires, Argentina.
Thrombos. Diethes, haemorh. (Stuttg.)
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The thrombotest reaction was carried out with 0.25 M Thrombotest reagent', to which 0.05 m]
of plasma or diluted plasma was added.
-Di,tuti,on 
(D) is defined as the ratio of the 6nal volume of a plasma samplo to its original volume.
Thus, undiluted plasma has a dilution factor of unity (D : 1). D .: n means that n-l volumes of
diluent were added to 1 volume of undiluted plasma.
A t-D ptot is a plot in which the clotting time (t") obtained with plasma at a known dilution (D)
is plotted along the Y-axis and the dilution along the X-axis. When the terrn "clotting-factor
concentration" is used in this context, we mean the concentration of the clotting factor that is
rate-Iimiting in these clotting-time estimations. This concentration is expressed as usual as a
percentage of the concentrat'ion in the pooled normal plasma.
Experimental Results
A t-D plot of normal plasma is essentially a reference curve in which t" is plotted
against the inverse of clotting-facto concontration.
In this special t-D curve, the clotting-factor concentration is by definition 100o/o at
D : 1, 50i/oat,D :2,33o/oaf D :-3, and generally 100-:no/o atI) : n. Thet-D
plot of normal plasma will be called the norrnal t-D plot. The shape of the normal t-D
itot *ith the T-hrombotest reagent is shown in n'igs. 1,2, and 3'.In these Figures each
ioint represents the mean of 50 estimations; four times the standard error of the mean
is rendeied as the diameter of the circle representing the clotting time'
The estimations were done in 5 groups, each group consisti.ng of tenfold estimations
of the thrombotest time in 7 diffeient filutions. The dilutions of each of the 5 groups
.were made independ"ently on different days. The dilutions of normal plasma shown in
Fig. 1 were mad; with buffer in plastic tubes; for those in Fig. 2 glass tubes were used.
Th"e dilutions in X'ig. 3 were toud. i.t plastic tubes with BaSOn absorbed oxalated'
plasma instead. of briffer. Fig. 4 shows tle dilution p]ot oJ normal plasma (black dots)
i,s well as the filqtion plo"ts of mixtures of BaSOn absorbed plasma and' nolmal
plasma ; the ratio of normlal plasma to absorbed pl-asm3 was_ 2 : 1 and. 1 : 2, respectively-
hg. S itrai"utes that there is a shortening of the thrombotest time when diluted
plisma is stored in glass tubes. This Figure also shows that this effect is enhanced by
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Fig. l. The normal t-D ptlotr. Pooled normal plasma, diluted with buffor in plastic tubes, tested with
Thrombotest reagent,.
Fig.2. The normal t-D 1tlot. Pooled normal plasma, diluted with buffer in glass tubes, tested with
Thrombotest reaEent.
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I'ig.3. The normal t-D pIoJ. Pooled normal plasma, diluted with BaSOn absorbed bovine plasma in
plastic tubes, tested with Thrombotest reagent.
I'ig. 4. The nornurl, t-D plot. TLrc normal t-D plot (A) compared with the t-D plot of 660/o normal
plasma in BaSOn absorbed plasma (B) and 33o/o normal plasma in BaSOn absorbed plasma (C).
kaolin but is absent in factor Xll-deficient plasma. Fig. 6 depicts the results demon-
strating that the.use of BaSOu absorbed plasma as a diluent shifts the optimal Ca,++
concentration to higher yalues. X'igs. 7, 8 and 9 show the normal t-D curves when
prothrombin times are estimated with human brain thromboplastin, Simplastin and
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Tig. 5. Thrombotest times aJterincubat'ion o! 1:10 d,iluted, plasma. A. factor Xll-deficient plasma in
glass tube. B. Normal plasma iri a plastic tube. C. Normal plasma in a glass tube. D. Normal plasma
in a plastic tube with kaolin (1.25 mg/ml).
Fig. 6. Thrombotest times of normal plo,sma a,t aa,r'ious Ca++ concentrati,ons, PLotted along the X-axis
is the Ca++ concentration in the fluid with which the thrombotest solution was made up. Lower
curve : undiluted plasma. Middle curves: normal plasma diluted 1 : 5. Upper curves: normal plasma
diluted 1 : 10. Solid line in left hand graph : dilutions made with Michaelis buffer; idem in right hand
graph: dilutions made with 10 mM oxalate in Michaelis buffer. Broken line in both graphs:
dilutions rnade with BaSOn absorbed plasma.
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Fig. 7. Normal, t-D graph of prothrombi,m ti,mes obta'ined u;'ith human thromboplasti,n Diluent: buffer
(circles) or BaSOn absorbed bovine plasma (dots). Reaction mixture: 0.1 mI (dilution of) normal
plasma; 0.1 mI thromboplastin; 0.1 ml CaCl, 25 mM.
Fig.8. Normal t-D graph obta'ined,toith Thromboplastin Roche. Diluent: buffer (circles) or BaSOn
absorbed bovine plasma (dots). Reaction mixture: 0.1 ml (dilution of) normal plasma;0.1 ml
thromboplastin; 0.1 ml CaCI, 25 mM.
Thromboplastin Roche. The dilutions were made with buffer as well as with BaSOn
absorbed plasma. Frg. 10 shows the results of using a factor X-deficient plasma rich in
faetors II and VII as a diluent, as compared" to buffer and BaSOn absorbed plasma.
X'ig. 11 gives the results of a comparable experiment with factor Vll-deficient plasma
replacing factor X-deficient plasma.
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Fig.9, Normal t-D graph obtai,ned, ui,th Bimplastirz. Diluent: buffer (circles) or BaSOn absorbed
bovineplasma (dots). Reactionmixture: 0.1mI (dilution of ) normalplasma;0.1mIthromboplastin;
0.1 ml CaCl, 25 rnM.
Fig. 10. Ihe nortnal t-D plot, obtai,ned, utith Thrombotest u'ith aarious d,'iluemts. O-O buffer as a
diluent,; O-O BaSOn absorbed plasma as a diluent; a-O factor X-deficient plasma
as a diluent; At D : 2, point Q and point I coincide.
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T heor etical C ons'id,erations
The t-D plot has some interesting features (see also 7). The line obtained with
dilutions of normal plasma can be used as a reference curve to read the clotting- factor
concentrations leading to an estimated. clotting time (t") in an unknown sample
(see n'ig. 12). The clotting-factor concentration in the sample can be calculated as
d/u x 100o/o
0 2 4 6 8 1 0
Ditut ion
X'ig. 11
Fig. 11. The normal t-D plot obto,ined ui,th thronlbotest u;'ith oarious d"iluents. O-O buffer as a
diluent; O-O factor Yll-deficient plasma as a diluent.
_ 
Fig. 12. The t-D Ttlot (see text).
It is clear t'hat the shorbest time theoretically available in this system is t*io, the
time inficated by the intercept of the reference curve and the Y-axis. When t.
equals tmin, ll equals O, so the clotting-factor concentration giving this clotting time
should equal infinity (d/u approaching infinity as u approaches zero). This means that
t-ia is the clotting time that would be obtained with an infinite concentration of the
rate-limiting clotting f actor.
Now let us assume that we have a plasma containing 50o/o of 16s 1afs-limiting
clotting factor in its undiluted form, and that we make serial dilutions of this plasma.
The unfiluted test plasma (D : 1) will then give the same clotting time as the twice-
filuted normal plasma (D : z).In general, a given dilution (D : n) of the 500/o
plasma will give the same clotting time as the normal plasma diluted twice as much
(D :2n). In the t-D plot the abnormal plasma will give a straight line, but a straight
Iinb twice as steep as the line obtained, with normal plasma.
In general, when a dilution series is mad.e of a test plasma with an unknown amount
of clotting factors present, the steepness of the line obtained with the test plasma,
relative to the steepness of the line obtained with normal plasma, will express the
amount of rate-limiting clotting factor in the plasma tested. This is demonstrated" in
Fig.4. Plasmas known to contain 660/o and 33o/" of the BaSOn adsorbable clotting
factors, show dilution graphs with cotangents that amount to 660/o and 33o/o of the
cotangent of the normal t-D line. In equation (cf. equation 30 from ref. 7).
o
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(1) tc .h : (1  ++) 1 0 0 ^  1t ,  +
x  
' *  ' E
Eig. 12
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where:
t" : clotting time at dilution D
h : a constant
K - areaction constant
E : an enzylJle concentration
x : the amount of "substrate" clotting factor in the plasma tested, expressed as a
percentage
D : dilution
It should be kept in mind that this formula is derived on the basis of the observed
analogies between the thrombotest system and the "simple" model of enzyme action
that serves as a basis for steadv-st ate errzyrme kinetics. This is permissable only i-f we
keep in mind that K, E and h may be complex constants and if there is evidence that
these constants do not vary in clifferent estimations compared in one graph.
When D approaches zero, Lhe first term of the formula approaches zero and tc
approaches t*i' (: Uh. E). It will be clear that t'oi1 will have to be constant,
independent, of the amount of rate-limiting clotting factor in the starting plasma (x),
proolded thrt E, the activity of the substance behaving as the enzyme in the observed
teaction, does not change, and provided that no mofifiers (e. g. inhibitors) are present
in the system.
I)iscussion
Figs. 1 and 3 show that in a thrombotest experiment the relation between clotting
time and dilution is linear when either buffer or absorbed plasma is used as a diluent.
Tig. 2 shows that the thrombotest time of high dilutions of normal plasma tends to
shorten when dilutions are made in glass tubes; this causes a slight deviation of the
straight-line relationship in this case.
Comparison of Figs. 1 and 3 indicates that dilution with absorbed plasma causes a
lengthening of the thrombotest time relative to an equal dilution with buffer. This may
be due to (a) the presence of antithrombin III in the absorbed plasma, (b) the presence
of a factor v inactivator in the absorbed plasma (8) and (c) the presence of a ca++
binfing entity in the absorbed plasma.
The experiment shown in n'ig. 6 demonstrates that the optimal Car-+ ion concentra-
tion in experiments il which the dilutions are made with BaSOn absorbed plasma,
tends to be hlgher than when the dilutions are done with either buffer or oxalated
buffer. Although this finding does not rule out the possible contribution of antithrom-
bin III or other inactivators, it stresses the importance of the Ca++ binding properties
in the BaSOo absorbed plasma as one of the factors determining the thrombotest
clotting time.
The acceleration of clotting by glass contact appears to be present in the system
tested in the thrombotest experiments as well as in the intrinsic system (9, t0, Ll, 12,
13). Fig. 5 shows that this activation is a time-dependent phenomenon enhanced by
kaolin and absent in factor Xll-deficient plasma. n'urther studies on this subject are in
progress in our laboratory. The fact that more dilute samples of plasma are mole
ieadily activated, seems to be accounted for by the relative abundance of wettable
surface in diluted samples. At any rate, it is clear that reliable estimation of the
normal t-D curve is possible only with the exclusion of surface activation.
Figs. 7, 8 and 9 show that the kind of relationship found with the Thrombotest
reagent, can be found with other thromboplastins as well. In this case, however,
dilution of factor V appears to cause a lengthening of clotting times, which seems to be
4
l
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relatively more pronounced in high dilutions and therefore the t-D curves prepared
with buffer as a diluent tend to bend upwards at the higher values of D. The experi-
mental results therefore suggest that the normal t-D curve is a straight line under
conditions including an abundance of factor V and no contact activation.
This finding of a simple straight-line relationship between clotting time and plasma
dilution is by no means simple to explain.
The over-all reaction of clottins in the extrinsic svstem is known to comprise a
minimum of 8 reactants (1,issue fa-ctor, factor VIf, faetor X,factor V,phospholipid,
factor II, factor I and calcium), 3 of which are varied simultaneously when dilutions
of normal plasma are added to the thrombotest reaction mixturb (factors VII, X
and II). If the over-all clotting rate of the mixture is determined by the concentrations
of all 3 factors, it is hard to see how a basically simple reaction between clotting time
and dilution would result (14).
When dilutions of normal plasma are added as a source of the factors II, VII, and X,
the ratio of the concentrations of these factors remains equal to the ratio found in the
original normal plasma (the "normal ratio"). This normal ratio might well represent a
functional excess of 1 or 2 of these factors over 1 or more of the others. The existence
of a functional excess is determined by the molar ratios of the factors and by the
reaction constants of their interaction, values which are not known at the moment.
The experiment shown in n'ig. 10 provides evidence that factor X is the clotting
factor that is rate-limiting when factors II, VIf, and X are present in a normal ratio.
This is clearly demonstrated, for instance, by the 1 : 10 dilution of the normal plasma in
this experiment. With buffer or absorbed plasma as a diluent, the concentration of
factors II, VII, and X in the sample is 10o/o, with factor X-deficient plasma as a
diluent the concentration of factor X is again 10o/o, whereas the concentration of
factors II andVII is 100o/o.Yet this tenfold increase of factors II andVII does not
appreciably shorten the clotting time. This indicates that the normal ratio of factorsll,
VIf, and X is such as to ensure a functional excess offactors II and VII over factor X
in this experimental situation.
This means that a thrombotest experiment is essentially a factor X estimation as
long as the ratio of factor X to factor VII and/or II does not appreciably exceed
the normal ratio. So the factor measured by estimating the slope of a t-D curve is
factor X.
Of course, this concept is not contradictory to the finding that isolated factor II or
factor VII deficiencies exhibit long thrombotest times, because in these cases the
ratio X'. X: F. II or T. X: F. VII greatly exceeds the normal ratio and factor II or
factor VII become rate-limitins.
The results shown in Fig. 11 stress this point. In the 1 : 10 dilution of normal plasma
with factor Vll-deficient plasma, i. e. in a situation in which l09o/o of fact'or II, 82o/o
of factor X* and llo/o of factor VII are present, the clotting time is appreciably
shorter than in the comparable dilution with either buffer, BaSOn absorbed plasma,
or factor X-deflcient plasma. Yet the clotting time is longer than in an experiment
\lrith 100% factor VII and82o/o factor X because of the fact that the ratio of factor X
to factor VII greatly exceeds the normal ratio in this particular experiment. The
situation is summarized in Table 1.
It is interesting to see that an increase of factor VII concentration does not shorten
the clotting time, whereas contact activation does. The most logical explanation of
this seems to be in terms of factor VII activation. We know that factor VII can be
*) 82"A factor X, because the original factor Vll-deficient plasma contains only 80o/o factor X.
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Table 1. Influence of Selective Yariation o{ Clottins Factors VII and X on the Thrombotest Time.
Sample
Composition (o/o) Clotting Time
(sec)F.  I I x'. vII F . X
A normal plasma
B factor YII-def. pl.
C factor X-def. pL
A in buf fer  1:10
A  i n  B  1 : 1 0
A  i n  C  1 : 1 0
100
1 1 0
105
1 0
109
tuj)
100
1 . 2
120
1 0
t 1
1 1 8
100
80
0.8
10
82
1 t
38
>500
>500
93
63
96
The clotting factor concentrations are given as filal concentrations in the sample tested,
expressed as a percentage of a normal pool,
conve?ted into activated factor VII (X'. VIIa) by a constituent of tho Thrombotest
reagent ("tissue factor") or by a contact activation product (13, 15). In a contact-free
thrombotest experiment a small fireil arnount, of tissue factor is present in every test.
If the substrate of the tissue factor (i. e. n'. VII) is present in excess, this situation
will lead to a velocity of VIIa formation that is determined by the concentration of
tissue factor rather than by the concentration of factor VII.
Because contact activation product acts on factor VII just as tissue factor does,
contact activation will cause a higher velocity of factor VII conversion and thus give
rise to a shorter clotting time. This is of course a grossly qualitative explanation.
Work on the actual kinetics of this process is in progress in our laboratory.
Summary
It is demonstrated that clotting time in a thrombotest experiment bears a linear
relationship to the inverse of factor X concentration under conditions in which the
ratio of factor X to the factors II and VII is equal to or smaller than the ratio in normal
plasma.
A similar relationship occurs with other thromboplastins as long as factor V and
fibrinogen are present in excess, i. e. when the dilutions are made with BaSOn absorbed
plasma.
Contact activation causes deviation from the observed straight-line relationship.
R6sum6
Il a 6t6 montr6 qu'il existe une relation lin6aire entre le temps de coagulation
d6termin6 par le thrombotest et I'inverse de la concentration en facteur X sous condi-
tion que le rapport du facteur X aux facteurs II et VII soit 6gal ou inf6rieur au
rapport normal plasmatique.
Une relation similaire apparait avec d'autres thromboplastines tant que le facteur V
et le fibrinogdne sont en excds c'est-iu-d.ire tant que les dilutions sont faites avec du
plasma adsorb6 par le BaSOn.
L'activation par contact cause une d6viation de la relation lin6aire observ6e.
Zusammenfassung
Es wird gezeigt, daB zwischen der Gerinnungszeit im Tbrombotest und dem rezi-
proken Wert der n'aktor-X-Konzentration eine lineare Beziehung besteht unter Be-
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dingungen, in welchen der Quotient von n'aktor X zu Faktor II und VII gleich oder
goringer ist als im Normalplasma.
Eine dhnliche Beziehung besteht mit anderen Thromboplastinen so lange, als
n'aktor V und n'ibrinogen im tlberschuB vorhanden sind, d. h., wenn die Verdiinnun-
gen mit bariumsulfatadsorbiertem Plasma hergestellt werden.
Die Kontaktaktivierung bewirkt eine Abweichung von der beobachteten gerad-
linigen Beziehung.
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